Method for infecting mesenchymal stem cells by Runx2 recombinant lentiviruses to express osteoblastic genes
A bone marrow mesenchymal and recombinant lentivirus technology, which is applied in genetic engineering, plant gene improvement, botany equipment and methods, etc., to achieve the effect of increased expression level, good cell growth, and improved expression level
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0021] In order to make the technical problems, technical solutions and beneficial effects to be solved by the present invention clearer, the present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
[0022] The lentiviral vector is obtained by transformation of human immunodeficiency virus (humanimmunodeficiency virus, HIV). The lentiviral vector system includes expression vector and packaging plasmid. Integrate the required genetic information. Compared with retroviruses, lentiviral vectors have obvious advantages: lentiviruses can infect non-dividing cells, allowing cells to maintain their characteristics; lentiviruses will not cause changes in gene expression of target cells, making them avoid secondary cancers. Compared with adenoviral vectors, lentiviral ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com